ZUG, Switzerland--(BUSINESS WIRE)--PSI CRO, a full-service contract research organization, announced today the appointment of Ayesha Karim to Head of Clinical Operations, Africa. This follows the recent announcement of PSI’s expansion into South Africa.
Ms. Karim has more than 15 years of experience in clinical research with a strong background in clinical operations management before joining PSI. Throughout her managerial career, Ms. Karim has also worked extensively in Regulatory Affairs and Ethics in South Africa, Kenya, and Malawi, to name a few. Ayesha brings a depth of pharmaceutical development expertise in running global projects in various therapeutic areas, including Oncology, Respiratory, Rheumatology, Renal Disorders, Allergies, Dermatology, Neurology, Endocrinology, Sepsis and HIV.
PSI will continue to grow its service offerings and access to all African countries from the PSI office in Pretoria. PSI’s ongoing therapeutic experience in South Africa stretches across the areas of Oncology, CNS, Urology, Nephrology, Diabetes and other major therapeutic areas. On-time delivery of high quality clinical trial data continues to be PSI’s key strength across all of the company’s operational locations.
About PSI CRO AG: PSI is a privately-held, full-service contract research organization (CRO), operating globally. PSI’s reputation on the market place is that of a no-nonsense CRO, capable of saving pharmaceutical sponsors millions of development dollars by consistently meeting clinical trial timelines. PSI’s global reach supports the operations of clinical trials across multiple countries and continents. PSI is known to be highly selective about the work that they pursue. PSI has exceptionally high repeat and referral business rates, while maintaining minimal staff turnover indicative of its commitment to be the best CRO in the world as measured by its customers and its employees. Global headquarters are located in Zug (Zürich), Switzerland at 113a Baarerstrasse 6300. www.psi-cro.com
